Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 196

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R(+)WIN55,212

Open access
Croxford, J. Ludovic, Miller, Stephen D.·2003·Journal of Clinical Investigation

Abstract

Theiler murine encephalomyelitis virus-induced demyelinating disease (TMEV-IDD) is a mouse model of chronic-progressive multiple sclerosis (MS) characterized by Th1-mediated CNS demyelination and spastic hindlimb paralysis. Existing MS therapies reduce relapse rates in 30% of relapsing-remitting MS patients, but are ineffective in chronic-progressive disease, and their effects on disability progression are unclear. Experimental studies demonstrate cannabinoids are useful for symptomatic treatment of spasticity and tremor in chronic-relapsing experimental autoimmune encephalomyelitis. Cannabinoids, however, have reported immunosuppressive properties. We show that the cannabinoid receptor agonist, R+WIN55,212, ameliorates progression of clinical disease symptoms in mice with preexisting TMEV-IDD. Amelioration of clinical disease is associated with downregulation of both virus and myelin epitope-specific Th1 effector functions (delayed-type hypersensitivity and IFN-gamma production) and the inhibition of CNS mRNA expression coding for the proinflammatory cytokines, TNF-alpha, IL1-beta, and IL-6. Clinical trials investigating the therapeutic potential of cannabinoids for the symptomatic treatment of MS are ongoing, and this study demonstrates that they may also have potent immunoregulatory properties.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci17652

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 53

  1. 10.1038/346183a0 · DOI · Paper page
  2. Goodin, 2002, Neurology., 58, 169, 10.1212/WNL.58.2.169 · DOI · Paper page
  3. Devane, 1988, Mol. Pharmacol., 34, 605
  4. 10.1111/j.1432-1033.1995.tb20780.x · DOI · Paper page
  5. 10.1016/S0167-5699(98)01300-0 · DOI · Paper page
  6. 10.2165/00023210-200317030-00004 · DOI · Paper page
  7. Baker, 2001, FASEB J., 15, 300, 10.1096/fj.00-0399fje · DOI · Paper page
  8. 10.1038/35003583 · DOI · Paper page
  9. 10.1089/088282401753266756 · DOI
  10. Pevear, 1987, J. Virol., 61, 1507, 10.1128/JVI.61.5.1507-1516.1987 · DOI · Paper page
  11. Lipton, 1975, Infect. Immun., 11, 1147, 10.1128/IAI.11.5.1147-1155.1975 · DOI · Paper page
  12. Miller, 1990, Semin. Virol., 1, 263
  13. Karpus, 1995, J. Immunol., 155, 947, 10.4049/jimmunol.155.2.947 · DOI
  14. 10.1038/nm1097-1133 · DOI · Paper page
  15. Croxford, 1998, J. Immunol., 160, 5181, 10.4049/jimmunol.160.10.5181 · DOI
  16. Croxford, 2000, J. Immunol., 164, 2776, 10.4049/jimmunol.164.5.2776 · DOI
  17. Croxford, 2001, J. Immunol., 166, 4124, 10.4049/jimmunol.166.6.4124 · DOI
  18. Olson, 2002, J. Immunol., 169, 2719, 10.4049/jimmunol.169.5.2719 · DOI
  19. Begolka, 1998, J. Immunol., 161, 4437, 10.4049/jimmunol.161.8.4437 · DOI · Paper page
  20. Killestein, 2002, Neurology., 58, 1404, 10.1212/WNL.58.9.1404 · DOI · Paper page
  21. Jacobs, 1991, J. Immunol., 146, 2983, 10.4049/jimmunol.146.9.2983 · DOI · Paper page
  22. Samoilova, 1998, J. Immunol., 161, 6480, 10.4049/jimmunol.161.12.6480 · DOI · Paper page
  23. 10.1002/ana.410300510 · DOI · Paper page
  24. 10.1002/(SICI)1097-4547(19960815)45:4<364::AID-JNR5>3.0.CO;2-7 · doi:10.1002/(sici)1097-4547(19960815)45:4<364::aid-jnr5>3.0.co;2-7
  25. 10.1046/j.1432-1033.2002.03078.x · DOI · Paper page
  26. 10.1016/S0165-5728(02)00370-3 · DOI · Paper page
  27. 10.1016/S0014-5793(98)00851-5 · DOI
  28. Molina-Holgado, 1997, Neuroreport., 8, 1929, 10.1097/00001756-199705260-00027 · DOI
  29. 10.1073/pnas.230436397 · DOI · Paper page
  30. Newton, 1994, Infect. Immun., 62, 4015, 10.1128/IAI.62.9.4015-4020.1994 · DOI
  31. Rowell, 1999, J. Immunol., 162, 1624, 10.4049/jimmunol.162.3.1624 · DOI
  32. Strle, 2001, Crit Rev. Immunol., 21, 427, 10.1615/CritRevImmunol.v21.i5.20 · DOI · Paper page
  33. 10.1159/000126646 · DOI · Paper page
  34. 10.1016/S0165-5728(97)00226-9 · DOI · Paper page
  35. 10.1016/S0024-3205(99)00286-6 · DOI
  36. 10.1016/S0165-5728(00)00349-0 · DOI
  37. Cabral, 1986, Proc. Soc. Exp. Biol. Med., 181, 305, 10.3181/00379727-181-42258 · DOI
  38. 10.1128/JVI.75.16.7420-7428.2001 · doi:10.1128/jvi.75.16.7420-7428.2001
  39. 10.1016/0162-3109(94)90056-6 · DOI
  40. 10.1016/0165-5728(89)90075-1 · DOI · Paper page
  41. 10.1016/S0165-5728(99)00149-6 · DOI
  42. 10.1073/pnas.160105897 · DOI · Paper page
  43. Ahmed, 2002, Am. J. Pathol., 161, 1577, 10.1016/S0002-9440(10)64436-7 · DOI
  44. 10.1084/jem.193.1.111 · DOI
  45. Molina-Holgado, 2002, J. Neurosci., 22, 9742, 10.1523/JNEUROSCI.22-22-09742.2002 · DOI · Paper page
  46. Werner, 2000, J. Neural Transm. Suppl., 60, 375
  47. 10.1038/sj.bjp.0701915 · DOI · Paper page
  48. 10.1074/jbc.272.35.22330 · DOI · Paper page
  49. 10.1002/syn.1075 · DOI
  50. 10.1016/S0014-2999(02)01369-9 · DOI
  51. Agurell, 1986, Pharmacol. Rev., 38, 21
  52. McPartland, 1999, Altern. Ther. Health Med., 5, 57
  53. Chan, 1987, Pediatrics., 79, 946

Cited by

See all 196

Metadata

Authors
Croxford, J. L., & Miller, S. D.
Venue
Journal of Clinical Investigation
Published
2003-04-15
Volume
111
Issue
8
Pages
1231-1240
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2097503043
Cited by
196
References
5
FWCI
11.64
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R(+)WIN55,212. https://app.cochat.ai/papers/10.1172/jci17652
The paper
Croxford, J. L., & Miller, S. D. (2003). Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R(+)WIN55,212. Journal of Clinical Investigation. https://doi.org/10.1172/jci17652

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.